Ben Gunawan
Queensland Health, QLD, Australia
Presentations this author is a contributor to:
Pembrolizumab for Metastatic Melanoma – One Year Results of Named Patient Access Program (#183)
3:00 PM
Vladimir Andelkovic
Posters1